Pathstone Family Office’s Adient ADNT Stock Holding History

Pathstone Family Office’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7	Closed	-$1K	–	384
2017 Q1	$1K	Buy	+7	New	+$460	﹤0.01%	422

Other funds holding ADNT

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pathstone Family Office's ADNT Position: Q2 2017 in Review

Pathstone Family Office sold out of Adient (ADNT) in Q2 2017, closing a stake of 7 shares — an estimated $1K sold.

Pathstone Family Office first reported a position in ADNT in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 398 funds tracked by Wall St. Rank hold ADNT as of Q2 2017.

Pathstone Family Office reported no remaining Adient position as of Q2 2017 after selling out during the quarter.
Pathstone Family Office sold 7 Adient shares in Q2 2017, an estimated $1K.
Pathstone Family Office first reported a position in Adient in Q1 2017 and held it in 1 quarter.
Pathstone Family Office's Adient position peaked at $1K in Q1 2017.
398 funds tracked by Wall St. Rank held Adient as of Q2 2017.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.